Mohammed Haneefa Nizamudeen/iStock via Getty Images The last year has not been a good one for Japanese pharma company Daiichi Sankyo ( DSNKY ) ( DSKYF ) (4568.T). From earnings misses to worries about clinical efficacy and safety to questions about corporate strategy, it’s been a period where investors have hammered the shares on bad news (real or perceived) while giving little credit for positive...
Mohammed Haneefa Nizamudeen/iStock via Getty Images The last year has not been a good one for Japanese pharma company Daiichi Sankyo ( DSNKY ) ( DSKYF ) (4568.T). From earnings misses to worries about clinical efficacy and safety to questions about corporate strategy, it’s been a period where investors have hammered the shares on bad news (real or perceived) while giving little credit for positive developments. Daiichi Sankyo ADRs are down about a third since my last update in January 2025 , significantly underperforming the Japanese pharmaceutical sector (by around 50% as measured by the TOPIX Pharmaceutical Index) and the Japanese market overall. Data by YCharts While key drug Enhertu continues to perform well and Datroway is off to a good start, upcoming readouts like the AVANZAR study are crucial for the stock, and I expect a lot of scrutiny over the upcoming announcement of the next five-year plan. These shares do look meaningfully undervalued today, but a lot is riding on a handful of studies now, and these shares are not suitable for investors who can’t handle above-average risk. Fiscal Third Quarter Results Didn’t Help Daiichi Sankyo’s third quarter was a relative relief after a very disappointing fiscal second quarter, but there really wasn’t much in the way of good news. Moreover, there were a few modest negatives that, in the absence of any offsetting positives, serve to feed the bearish narrative for now. Revenue rose 11% in constant currency for the quarter. Overall, Enhertu revenues were up 37%, with a 32% increase in product revenue. Year-over-year comparisons for Datroway aren’t useful yet, but the 45% sequential growth was better than expected, and management once again raised full-year guidance for this drug. Key legacy drug Lixiana saw 4% revenue growth, and collectively these three compounds are about 60% of total revenue. Gross margin improved almost six points to 79.1%, and operating profit rose 45%, with the operating margin improving about th...
Anyone who paid the taxes should get reimbursed, but the high court did not address how. Business owners wonder if they'll need lawyers, brokers, money — or luck. (Image credit: ASM Games)
Anyone who paid the taxes should get reimbursed, but the high court did not address how. Business owners wonder if they'll need lawyers, brokers, money — or luck. (Image credit: ASM Games)
An NPR investigation finds the public database of Epstein files is missing dozens of pages related to sexual abuse accusations against President Trump. (Image credit: Department of Justice and Getty Images/Collage by Danielle A. Scruggs/NPR)
An NPR investigation finds the public database of Epstein files is missing dozens of pages related to sexual abuse accusations against President Trump. (Image credit: Department of Justice and Getty Images/Collage by Danielle A. Scruggs/NPR)
Nvidia's Q4 is expected to be enormous, but its stock now trades on the slope: guidance, margins, and proof that the AI spend curve is still steepening
Nvidia's Q4 is expected to be enormous, but its stock now trades on the slope: guidance, margins, and proof that the AI spend curve is still steepening
'Out Of Africa': Beijing Slashes Investment Up To 85% Authored by James Gorrie via The Epoch Times, For more than a decade, China’s footprint across Africa has expanded at a phenomenal pace. Railways in Kenya, ports in Tanzania, energy projects across sub-Saharan Africa, and militarized infrastructure in various places have meant billions in state-backed loans. For decades, Beijing has positioned ...
'Out Of Africa': Beijing Slashes Investment Up To 85% Authored by James Gorrie via The Epoch Times, For more than a decade, China’s footprint across Africa has expanded at a phenomenal pace. Railways in Kenya, ports in Tanzania, energy projects across sub-Saharan Africa, and militarized infrastructure in various places have meant billions in state-backed loans. For decades, Beijing has positioned itself as Africa’s largest trading partner and its most aggressive infrastructure financier. But something has changed. In some sectors, such as energy lending by Chinese development finance institutions, investment levels have fallen by as much as 85 percent from their peak years. That’s not a rounding error, that’s a strategic retreat. What’s really going on? Is China walking away from Africa? Or is Africa revealing something deeper about China’s own economic stress? It’s all of the above and more. The Pullback Is Real—and Sharp According to research cited by the Clean Air Task Force, Chinese development finance for African energy projects has declined roughly 85 percent since 2015. That’s a dramatic contraction in capital deployment. Separate reporting based on data from Boston University’s Global Development Policy Center shows that Chinese lending to Africa has fallen sharply in recent years. In some reports, China’s investment fell nearly 46 percent year over year in 2024 . This isn’t just a pause. It’s a reset. For years, Beijing fueled infrastructure growth across the continent through state-backed loans tied to its Belt and Road Initiative expansion . Now, the tap isn’t fully off, but it’s not flowing as freely as it used to. China Isn’t Leaving Africa, but It’s Changing How It Engages Before jumping to the “China is out of Africa” conclusion, it’s important to note a few critical facts. For one, China remains Africa’s largest trading partner. Trade volumes remain substantial and have even grown in recent years. But lending and investment are different from trade. ...
CBOE shares have outperformed the beloved Mag 7 group as a whole not just in 2026 but over the past year as well, with record-breaking results regularly giving shares a boost.
CBOE shares have outperformed the beloved Mag 7 group as a whole not just in 2026 but over the past year as well, with record-breaking results regularly giving shares a boost.
The deaths of 72 captive tigers at a private park popular with tourists in northern Thailand have renewed scrutiny of a lucrative industry that campaigners warn treats wild animals as “entertainment”. The outbreak at Tiger Kingdom in Chiang Mai began in early February, with authorities initially attributing the deaths to canine distemper – a virus carried by dogs but often fatal to big cats. A dee...
The deaths of 72 captive tigers at a private park popular with tourists in northern Thailand have renewed scrutiny of a lucrative industry that campaigners warn treats wild animals as “entertainment”. The outbreak at Tiger Kingdom in Chiang Mai began in early February, with authorities initially attributing the deaths to canine distemper – a virus carried by dogs but often fatal to big cats. A deeper investigation is under way, with some medical experts suspecting contaminated food may have been...
In this article TSLA BYD Follow your favorite stocks CREATE FREE ACCOUNT Elon Musk, chief executive officer of Tesla Inc., during the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 22, 2026. Bloomberg | Bloomberg | Getty Images U.S. electric vehicle maker Tesla 's sales in Europe were down for a 13th consecutive month in January, while its biggest Chinese rival saw another sur...
In this article TSLA BYD Follow your favorite stocks CREATE FREE ACCOUNT Elon Musk, chief executive officer of Tesla Inc., during the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 22, 2026. Bloomberg | Bloomberg | Getty Images U.S. electric vehicle maker Tesla 's sales in Europe were down for a 13th consecutive month in January, while its biggest Chinese rival saw another surge. Data published Tuesday by industry lobby group ACEA, or the European Automobile Manufacturers Association, found that Tesla's new car registrations fell to 8,075 in January, down 17% from a year ago, representing the 13th consecutive month in which sales have shrunk. Tesla's market share across the European Union, Britain, Switzerland, Norway and Iceland fell to 0.8%, meanwhile, down from 1% in the same month last year. It marks another "very weak" start of the new year for Elon Musk 's company, Rico Luman, senior sector economist for transport and logistics at Dutch bank ING, told CNBC by email. "Tesla's image has deteriorated in Europe last year and people have much more choice now with the range of new affordable EVs (including those of BYD and others like MG and ZEEKR) entering the market, while Tesla lacks new models," he added. Tesla's focus on autonomous driving , rather than introducing new vehicles and expanding its range of mass models, is likely a factor too, Luman said. "Another thing in Europe is that large numbers of first generations of Tesla's are remarketed at the moment (after being leased for 4-6 years), this has driven second hand prices down," Luman said, adding that there's an abundance of competitively priced Tesla's available on the used market. A Tesla car is being charged at a Tesla electrical vehicle charging station in Norheimsund, Norway, Aug. 22, 2025. Sergei Gapon | Afp | Getty Images Tesla has been beset by challenges in Europe , including robust competition, particularly from Chinese car brands. It's also struggled to shake off reputatio...
Oleh_Slobodeniuk/E+ via Getty Images Introduction VanEck Vietnam ETF ( VNM ) is an exchange-traded fund that seeks to replicate the performance of its chosen benchmark index, the MarketVector™ Vietnam Local Index (MVVNMLTR), which tracks securities of publicly traded companies that are locally incorporated in Vietnam. VNM is a well-known Vietnam-tracking ETF offered by VanEck , with an expense rat...
Oleh_Slobodeniuk/E+ via Getty Images Introduction VanEck Vietnam ETF ( VNM ) is an exchange-traded fund that seeks to replicate the performance of its chosen benchmark index, the MarketVector™ Vietnam Local Index (MVVNMLTR), which tracks securities of publicly traded companies that are locally incorporated in Vietnam. VNM is a well-known Vietnam-tracking ETF offered by VanEck , with an expense ratio of 0.68% (not cheap) and assets under management of $648.17 million as of February 20, 2026. The ETF was set up in November 2009. Holdings and Sector Exposures VNM has 54 holdings, with significant sector exposures including Financial Services (31.14%), Real Estate (27.25%), Industrials (16.90%), and Consumer Defensive (10.83%). Morningstar The Vietnamese stock market lacks the kind of breadth you see in more developed markets, but the concentration at the top is not too fierce. The largest holdings are Vingroup JSC, a private Vietnamese conglomerate, at 8.42%; Vinhomes JSC, the largest commercial real estate developer in Vietnam, at 8.22%; and Masan Group Corp., one of the top three largest private sector conglomerate companies in Vietnam, at 6.91%. The most up-to-date holdings information can be found here . Cyclical Positioning The VNM portfolio is reasonably balanced but overweight in sectors that are generally mature and defensive. The portfolio is essentially a soft bet on the Vietnamese business economy and, to perhaps some extent, a bet on a stronger local currency vs. the dollar (adjusted for interest rates). More broadly, VNM is a more specific bet on emerging markets in Asia. Emerging market equities tend to perform best when growth is accelerating and rates are falling. Global central bank posture is currently in a neutral-easing stance while the growth picture looks neutral-positive . All considered, VNM is cyclically reasonably well positioned, and the portfolio does not look especially problematic from a concentration standpoint, particularly if the ETF re...
wildpixel/iStock via Getty Images China has banned the export of dual-use items, including rare earths, to 20 Japanese entities to curb Japan's remilitarization, the latest escalation of its months-long dispute with Tokyo over Taiwan. The ban targets Japanese entities including Mitsubishi Heavy Industries' ( MHVYF ) ( MHVIY ) shipbuilding and aerospace units, Kawasaki Heavy Industries' ( KWHIY ) (...
wildpixel/iStock via Getty Images China has banned the export of dual-use items, including rare earths, to 20 Japanese entities to curb Japan's remilitarization, the latest escalation of its months-long dispute with Tokyo over Taiwan. The ban targets Japanese entities including Mitsubishi Heavy Industries' ( MHVYF ) ( MHVIY ) shipbuilding and aerospace units, Kawasaki Heavy Industries' ( KWHIY ) ( KWHIF ) aerospace division, and Fujitsu Defense & National Security, China's commerce ministry announced . The export control applies to over 800 dual-use items that can be used both for civilian and military purposes, such as critical minerals, electronics, chemicals, and pharmaceuticals. The commerce ministry also added 20 other Japanese entities — whose end-users and end uses of dual-use items can't be verified — to a watchlist. These include Subaru ( FUJHY ), Sumitomo Heavy Industries ( SOHVY ), ITOCHU Aviation, and Mitsubishi Materials ( MIMTF ). "These measures aim to curb Japan's 'remilitarization' and nuclear ambitions, and are entirely legitimate, reasonable, and legal," the ministry's spokesperson said. "They will not affect normal Sino-Japanese economic and trade exchanges, and law-abiding Japanese entities have absolutely nothing to worry about." Kei Sato, Japan's deputy chief cabinet secretary, said China's moves are "unacceptable and extremely regrettable" and demanded their immediate withdrawal. "We will carefully examine the details and potential impact of these measures and take all necessary steps in response," he added. Tensions escalated between Beijing and Tokyo over Japanese Prime Minister Sanae Takaichi's comments late last year, in which she implied that Japan could intervene if Taiwan were attacked. More on China, Japan Chinese Stocks, FXI After SCOTUS' Tariff Ruling Is China Really Dumping U.S. Treasuries? Japan's Moment: Elections, Flows And Global Opportunities Japan's Election Shock: The Yen Trade Wall Street Can't Ignore
Willie B. Thomas/DigitalVision via Getty Images Investment thesis Could Main Street Capital Corporation ( MAIN ) be considered a reasonable bond complement? In this article, we explore the pros and cons and conclude that it would be a solid candidate for investors who want incremental yield gains, diversification, and extra protection against inflation. We also examine which types of investors mig...
Willie B. Thomas/DigitalVision via Getty Images Investment thesis Could Main Street Capital Corporation ( MAIN ) be considered a reasonable bond complement? In this article, we explore the pros and cons and conclude that it would be a solid candidate for investors who want incremental yield gains, diversification, and extra protection against inflation. We also examine which types of investors might use MAIN this way and those who should not. What is a bond complement? It is a security that can help increase investors’ income, help mitigate inflation, and provide diversification for a bond portfolio or a portfolio heavily weighted to bonds. For example, BlackRock describes its BlackRock Strategic Income Opportunities Portfolio Investor C Shares ( BSICX ) as a “Flexible, core bond complement”. It adds that the fund seeks to diversify across markets and strategies while seeking total returns that are consistent with the preservation of capital. Asset classes that make good complements include real estate investment trusts, preferred shares, infrastructure income stocks, dividend Aristocrats, and BDCs (Business Development Companies). Why MAIN is a complement candidate MAIN is a BDC and apparently an aspiring Dividend Aristocrat. Regarding the former, a BDC must, by law, distribute 90% or more of its taxable income to hold its pass-through tax status. This means BDCs often retain less of their earnings and pass more along to their shareholders. To put it another way, MAIN is structurally bound to maintain its reasonably high dividends. It can only maintain its dividends, though, if it can avoid bad investments and continue to generate earnings. To that end, it has a conservative approach to its business, as some facts in this table from its Q3 2025 earnings report confirm: MAIN portfolio summary table (Q3 2025 earnings report) First, note the diversification that comes from putting capital into both debt and equity. The company also tells us its debt and equity investm...